|
1
|
Melvin WS and Wilkinson MG: Gastric
schwannoma. Clinical and pathologic considerations. Am Surg.
59:293–296. 1993.PubMed/NCBI
|
|
2
|
Braumann C, Guenther N, Menenakos C and
Junghans T: Schwannoma of the colon mimicking carcinoma: A case
report and literature review. Int J Colorectal Dis. 22:1547–1548.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jacobson BC, Hirsch MS, Lee JH, Van Dam J,
Shoji B and Farraye FA: Multiple asymptomatic plexiform schwannomas
of the sigmoid colon: A case report and review. Gastrointest
Endosc. 53:801–804. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tokunaga T, Takeda S, Sumimura J and Maeda
H: Esophageal schwannoma: Report of a case. Surg Today. 37:500–502.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kitada M, Matsuda Y, Hayashi S, Ishibashi
K, Oikawa K and Miyokawa N: Esophageal schwannoma: A case report.
World J Surg Oncol. 11:2532013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirose T, Ishizawa K, Sakaki M and Fujii
Y: Retroperitoneal schwannoma is characterized by a high incidence
of cellular type and GFAP-immunoreactivity. Pathol Int. 62:456–462.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarlomo-Rikala M and Miettinen M: Gastric
schwannoma - a clinicopathological analysis of six cases.
Histopathology. 27:355–360. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lasota J and Miettinen M: Clinical
significance of oncogenic KIT and PDGFRA mutations in
gastrointestinal stromal tumours. Histopathology. 53:245–266. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ogasawara N, Sasaki M, Ishiguro H, Itoh Y,
Nojiri S, Kubota E, Wada T, Kataoka H, Kuwabara Y and Joh T:
Gastric schwannoma with adjacent external progression harbored
aberrant NF2 gene. Dig Endosc. 21:192–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Díaz Ståhl T, Hansson CM, de Bustos C,
Mantripragada KK, Piotrowski A, Benetkiewicz M, Jarbo C, Wiklund L,
Mathiesen T, Nyberg G, et al: High-resolution array-CGH profiling
of germline and tumor-specific copy number alterations on
chromosome 22 in patients affected with schwannomas. Hum Genet.
118:35–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Voltaggio L, Murray R, Lasota J and
Miettinen M: Gastric schwannoma: A clinicopathologic study of 51
cases and critical review of the literature. Hum Pathol.
43:650–659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Snyder RA, Harris E, Hansen EN, Merchant
NB and Parikh AA: Gastric schwannoma. Am Surg. 74:753–756.
2008.PubMed/NCBI
|
|
13
|
Miettinen M and Lasota J: Histopathology
of gastrointestinal stromal tumor. J Surg Oncol. 104:865–873. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miettinen M, Sobin LH and Sarlomo-Rikala
M: Immunohistochemical spectrum of GISTs at different sites and
their differential diagnosis with a reference to CD117 (KIT). Mod
Pathol. 13:1134–1142. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papaetis GS and Syrigos KN: Targeted
therapy for gastrointestinal stromal tumors: Current status and
future perspectives. Cancer Metastasis Rev. 29:151–170. 2010.
View Article : Google Scholar : PubMed/NCBI
|
